The Study of Percutaneous Mechanical Thrombectomy Treating Acute Deep Vein Thrombosis of Lower Extremities
NCT ID: NCT05356767
Last Updated: 2022-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2022-04-01
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
NCT02959801
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
NCT02414802
Safety and Efficacy Study of Endovenous Microwave Ablation for Treatment of Varicose Veins
NCT04645771
Venous Thromboembolism (VTE) Knowledge
NCT05548010
Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
NCT06468150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
post-thromboticsyndrome
suffering from PTS (Villalta score) at 2 years after operation.
Pharmacomechanical thrombolysis
Pharmacomechanical thrombolysis
n-post-thromboticsyndrome
none of PTS (Villalta score) at 2 years after operation.
Pharmacomechanical thrombolysis
Pharmacomechanical thrombolysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacomechanical thrombolysis
Pharmacomechanical thrombolysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Lower extremity deep venous thrombosis involving iliac vein or / and femoral vein ;
3. Obtain the informed consent of all patients.
Exclusion Criteria
2. patients who are prohibited from thrombolytic therapy;
3. inferior vena cava compression syndrome；
4. Allergic to heparin, low molecular weight heparin or contrast medium;
5. Patients who have participated in clinical trials of other drugs or medical devices that interfere with this clinical trial in the past 3 months;
6. Patients who do not want to participate in this trial;
7. Patients with poor compliance, or those who the researchers think are not suitable for selection.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chengdu University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chunshui He
the director of the vascular surgery of Hospital of Chengdu University of Traditional Chinese Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meng Ye, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator RenJi Hospital
Ziheng Wu, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Zhejiang University
Lianrui Guo, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Xuanwu Hospital, Beijing
Xin Fang, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Hangzhou first people's Hospital of Medical College of Zhejiang University
Hongfei Sang, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Second Affiliated Hospital of Suzhou University
Qiang Li, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Qingdao Haici Hospital affiliated to Qingdao University
Zibo Feng, doctor
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Zhenyu Shi, doctor
Role: PRINCIPAL_INVESTIGATOR
Shanghai Zhongshan Hospital
Weihao Shi, doctor
Role: PRINCIPAL_INVESTIGATOR
Huashan Hospital
Wensheng Lou, doctor
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital With Affiliated Nanjing Medical University
Hui Zhao, doctor
Role: PRINCIPAL_INVESTIGATOR
Affiliated Hospital of Nantong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chunshuihe
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ChengduUTCMvs3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.